日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancer

1q24.1 处的常见变异(ALDH9A1)是肾癌的潜在风险因素。

Marc Y R Henrion ,Mark P Purdue ,Ghislaine Scelo ,Peter Broderick ,Matthew Frampton ,Alastair Ritchie ,Angela Meade ,Peng Li ,James McKay ,Mattias Johansson ,Mark Lathrop ,James Larkin ,Nathaniel Rothman ,Zhaoming Wang ,Wong-Ho Chow ,Victoria L Stevens ,W Ryan Diver ,Demetrius Albanes ,Jarmo Virtamo ,Paul Brennan ,Timothy Eisen ,Stephen Chanock ,Richard S Houlston

Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab

接受化疗±西妥昔单抗治疗的晚期结直肠癌患者的肿瘤中表皮生长因子受体通路的体细胞分析

Christopher G Smith, David Fisher, Bart Claes, Timothy S Maughan, Shelley Idziaszczyk, Gilian Peuteman, Rebecca Harris, Michelle D James, Angela Meade, Bharat Jasani, Richard A Adams, Sarah Kenny, Richard Kaplan, Diether Lambrechts, Jeremy P Cheadle

Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer

2q22.3 处的常见变异 (ZEB2) 会影响肾癌的风险

Marc Henrion ,Matthew Frampton, Ghislaine Scelo, Mark Purdue, Yuanqing Ye, Peter Broderick, Alastair Ritchie, Richard Kaplan, Angela Meade, James McKay, Mattias Johansson, Mark Lathrop, James Larkin, Nathaniel Rothman, Zhaoming Wang, Wong-Ho Chow, Victoria L Stevens, W Ryan Diver, Susan M Gapstur, Demetrius Albanes, Jarmo Virtamo, Xifeng Wu, Paul Brennan, Stephen Chanock, Timothy Eisen, Richard S Houlston